| SARS-CoV-2 Omicron variant neutralization in serum from vaccinated and convalescent persons A Rössler, L Riepler, D Bante, D von Laer, J Kimpel New England Journal of Medicine 386 (7), 698-700, 2022 | 397 | 2022 |
| Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases A Zollner, R Koch, A Jukic, A Pfister, M Meyer, A Rössler, J Kimpel, ... Gastroenterology 163 (2), 495-506. e8, 2022 | 196 | 2022 |
| Successful return to professional men’s football (soccer) competition after the COVID-19 shutdown: a cohort study in the German Bundesliga T Meyer, D Mack, K Donde, O Harzer, W Krutsch, A Rössler, J Kimpel, ... British journal of sports medicine 55 (1), 62-66, 2021 | 123 | 2021 |
| Comparison of four SARS-CoV-2 neutralization assays L Riepler, A Rössler, A Falch, A Volland, W Borena, D von Laer, J Kimpel Vaccines 9 (1), 13, 2020 | 111 | 2020 |
| SARS-CoV-2 B. 1.1. 529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals A Roessler, L Riepler, D Bante, D von Laer, J Kimpel MedRxiv, 2021 | 100 | 2021 |
| B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19 A Zollner, C Watschinger, A Rössler, MR Farcet, A Penner, V Böhm, ... EBioMedicine 70, 2021 | 85 | 2021 |
| Neutralization profile after recovery from SARS-CoV-2 omicron infection A Rössler, L Knabl, D von Laer, J Kimpel New England Journal of Medicine 386 (18), 1764-1766, 2022 | 81 | 2022 |
| High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl L Knabl, T Mitra, J Kimpel, A Rössler, A Volland, A Walser, H Ulmer, ... Communications medicine 1 (1), 4, 2021 | 65 | 2021 |
| BA. 2 and BA. 5 omicron differ immunologically from both BA. 1 omicron and pre-omicron variants A Rössler, A Netzl, L Knabl, H Schäfer, SH Wilks, D Bante, ... Nature communications 13 (1), 7701, 2022 | 52 | 2022 |
| Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: the pragmatic, multi-center, three-arm, partially randomized … Z Bánki, J Mateus, A Rössler, H Schäfer, D Bante, L Riepler, A Grifoni, ... EBioMedicine 80, 2022 | 32 | 2022 |
| Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment I Koske, A Rössler, L Pipperger, M Petersson, I Barnstorf, J Kimpel, ... International journal of cancer 145 (7), 1958-1969, 2019 | 31 | 2019 |
| Marked increase in avidity of SARS-CoV-2 antibodies 7–8 months after infection is not diminished in old age D Pichler, M Baumgartner, J Kimpel, A Rössler, L Riepler, K Bates, ... The Journal of Infectious Diseases 224 (5), 764-770, 2021 | 29 | 2021 |
| Prevalence of SARS-CoV-2 IgG antibodies in a large prospective cohort study of elite football players in Germany (May–June 2020): implications for a testing protocol in … D Mack, BC Gärtner, A Rössler, J Kimpel, K Donde, O Harzer, W Krutsch, ... Clinical Microbiology and Infection 27 (3), 473. e1-473. e4, 2021 | 21 | 2021 |
| N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) in vitro M Lackner, A Rössler, A Volland, MN Stadtmüller, B Müllauer, Z Banki, ... Emerging Microbes & Infections 11 (1), 1293-1307, 2022 | 19 | 2022 |
| Reduced sensitivity of antibody tests after omicron infection A Rössler, L Knabl, LM Raschbichler, E Peer, D von Laer, W Borena, ... The Lancet Microbe 4 (1), e10-e11, 2023 | 16 | 2023 |
| Persistence of immunity to SARS-CoV-2 over time in the ski resort Ischgl W Borena, Z Bánki, K Bates, H Winner, L Riepler, A Rössler, L Pipperger, ... EBioMedicine 70, 2021 | 15 | 2021 |
| Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography A Rössler, A Netzl, L Knabl, D Bante, SH Wilks, W Borena, D Von Laer, ... Nature Communications 14 (1), 5224, 2023 | 12 | 2023 |
| The anti-histamine azelastine, identified by computational drug repurposing, inhibits infection by major variants of SARS-CoV-2 in cell cultures and reconstituted human nasal … R Konrat, H Papp, J Kimpel, A Rössler, V Szijártó, G Nagy, M Madai, ... Frontiers in pharmacology 13, 861295, 2022 | 11 | 2022 |
| Neutralization profile of Omicron variant convalescent individuals A Rössler, L Knabl, D Laer, J Kimpel medRxiv, 2022.02. 01.22270263, 2022 | 11 | 2022 |
| Chemogenetic ON and OFF switches for RNA virus replication E Heilmann, J Kimpel, B Hofer, A Rössler, I Blaas, L Egerer, T Nolden, ... Nature communications 12 (1), 1362, 2021 | 9 | 2021 |
